Medical Devices Australia

Australia Hormone Testing at Home Market Analysis, 2024–2034

Updated Reviewed by Chandani Patel

Australia Hormone Testing at Home Market Industry Trends and Forecast to 2034: Segmented by (Hormone, Sample, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

Australia · 2024–2034 · placeholder estimates

Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $10.5 Mn Placeholder estimate
Estimate 2025 $11.7 Mn 1.4% of the global market
Projected 2034 $30.8 Mn 164.2% Adds $19.2 Mn over 9 forecast years
CAGR 2025–2034 11.4% Faster than 61% of 173 Medical Devices markets here
Key players 5 Companies profiled
  • Australia is 1.38% of the global market.
  • In APAC, the largest is China at $61.6 Mn.
  • Fastest growing: India at 12.6% a year.
  • Australia ranks 4th of 10 by size in APAC.

Market size projection

Australia

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$19.2 Mn total, 2026–2034

Year-by-year market size, 2024–2034
Hormone Testing at Home Market market size by year, Australia
YearMarket sizeChange that yearSince 2025
2024 (estimate) $10.5 Mn — —
2025 (base) $11.7 Mn +$1.2 Mn —
2026 (forecast) $13.0 Mn +$1.3 Mn +11.4%
2027 (forecast) $14.5 Mn +$1.5 Mn +24.1%
2028 (forecast) $16.1 Mn +$1.7 Mn +38.2%
2029 (forecast) $18.0 Mn +$1.8 Mn +54%
2030 (forecast) $20.0 Mn +$2.0 Mn +71.6%
2031 (forecast) $22.3 Mn +$2.3 Mn +91.1%
2032 (forecast) $24.8 Mn +$2.5 Mn +112.9%
2033 (forecast) $27.7 Mn +$2.8 Mn +137.2%
2034 (forecast) $30.8 Mn +$3.2 Mn +164.2%

Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Report snapshot

Australia Hormone Testing at Home Market Analysis at a glance
Market size, 2025$11.7 Mn placeholder estimate
Forecast, 2034$30.8 Mn placeholder estimate
Growth (CAGR), 2025–203411.4% placeholder estimate
Years2024 historical · 2025 base year · 2026–2034 forecast
SegmentsHormone, sample and end user (see all)
Key playersEverlywell, LetsGetChecked, Thorne, Mira, Hims & Hers Health (see all)
Regulator in AustraliaTGASource: Therapeutic Goods Administration. Checked 14 Nov 2026.
FormatsPDF, PPTX, XLSX

Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.

The Australia Hormone Testing at Home Market Analysis Executive Summary

At-home hormone tests measure hormones such as estrogen, thyroid, cortisol and testosterone from finger-prick blood or saliva.

Key segments of the hormone Testing at Home market include hormone (Female Sex Hormones, Thyroid and Cortisol) and sample (Blood, Saliva and Urine).

Bar chart: Australia Hormone Testing at Home market size, 2024–2034, placeholder estimates. $10.5 Mn in 2024, $11.7 Mn in 2025 and $30.8 Mn in 2034, 11.4% CAGR.
Australia Hormone Testing at Home market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.

Australia Hormone Testing at Home Market Dynamics

Market Growth Drivers

Greater awareness of women's health needs, more funding for female-focused research, later pregnancies and an ageing female population are driving the hormone Testing at Home market. New products designed around women's biology and digital care are improving access.

Opportunity

Femtech, personalised care and new treatments for under-served conditions open strong growth for the hormone Testing at Home market, especially as employers and payers add women's health benefits.

Market Restraints

Under-diagnosis, stigma around some conditions, limited insurance coverage and a long history of under-research in women's health hold back the hormone Testing at Home market.

Competitive Landscape for Hormone Testing at Home Market in Australia

The hormone Testing at Home market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for Hormone Testing at Home Market in Australia

Hormone Testing at Home in Australia: rules and payment

Medical devices must be included in the Australian Register of Therapeutic Goods (ARTG), run by the Therapeutic Goods Administration (TGA), before they can be supplied.⁠[1] Medicare pays for public hospital care and many doctor visits, and the Pharmaceutical Benefits Scheme (PBS) subsidises listed medicines.⁠[2]

[1] Therapeutic Goods Administration. Checked 14 Nov 2026.

[2] Pharmaceutical Benefits Scheme. Checked 14 Nov 2026.

Policy changes and Reimbursement scenario

Medical device rules, such as the US FDA 510(k) and PMA pathways and the EU Medical Device Regulation, govern how hormone Testing at Home products are approved and monitored. Reimbursement codes and hospital purchasing policies decide how widely they are used in Australia.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in Hormone Testing at Home right now, from free public sources.

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

Hormone Testing at Home in context

Australia compared

  • Health spending per person: 6,980 US$ per person (2023). World: 1,317 US$ per person (2023). Highest of the 15 countries we cover in APAC.[1]
  • Doctors: 4.09 per 1,000 people (2022). World: 1.86 per 1,000 people (2022). Highest of the 15 countries we cover in APAC.[2]
  • People aged 65 and over: 18.1% of people (2025). World: 10.4% of people (2025). 3rd highest of the 16 countries we cover in APAC.[3]

[1] World Bank Open Data, Health spending per person (US$ per person). Retrieved 15 Nov 2026.

[2] World Bank Open Data, Doctors (per 1,000 people). Retrieved 16 Nov 2026.

[3] World Bank Open Data, People aged 65 and over (% of people). Retrieved 16 Nov 2026.

Free data on this topic

Quick answers

Frequently asked questions

How big is the Hormone Testing at Home market in Australia?
Placeholder estimate: about $11.7 Mn in 2025, rising to about $30.8 Mn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the Hormone Testing at Home market in Australia growing?
Placeholder estimate: about 11.4% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the Hormone Testing at Home market report cover?
The report splits the market by hormone (Female Sex Hormones, Thyroid, Cortisol, Testosterone), sample (Blood, Saliva, Urine) and end user (Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, Home Care Settings).
Who are the key players in the Hormone Testing at Home market?
Key players include Everlywell, LetsGetChecked, Thorne, Mira and Hims & Hers Health.
What is driving the Hormone Testing at Home market?
Greater awareness of women's health needs, more funding for female-focused research, later pregnancies and an ageing female population are driving the hormone Testing at Home market. New products designed around women's biology and digital care are improving access.
Who regulates Hormone Testing at Home in Australia?
Medical devices must be included in the Australian Register of Therapeutic Goods (ARTG), run by the Therapeutic Goods Administration (TGA), before they can be supplied. Source: Therapeutic Goods Administration. Checked 14 Nov 2026.
How is healthcare paid for in Australia?
Medicare pays for public hospital care and many doctor visits, and the Pharmaceutical Benefits Scheme (PBS) subsidises listed medicines. Source: Pharmaceutical Benefits Scheme. Checked 14 Nov 2026.
Back to Catalogue

Related Medical Devices reports in Australia

See all

Related on women's health and diagnostics and lab testing

See the topic